IMMUNOCORE HLDGS PLC's ticker is IMCR and the CUSIP is 45258D105. A total of 127 filers reported holding IMMUNOCORE HLDGS PLC in Q3 2023. The put-call ratio across all filers is 0.01 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,265,841 | +21.7% | 24,390 | +40.6% | 0.00% | – |
| Q2 2023 | $1,040,066 | +45.5% | 17,346 | +20.0% | 0.00% | – |
| Q1 2023 | $714,803 | +86542.8% | 14,458 | 0.0% | 0.00% | – |
| Q4 2022 | $825 | -99.9% | 14,458 | -12.2% | 0.00% | – |
| Q3 2022 | $772,000 | +25.7% | 16,464 | 0.0% | 0.00% | – |
| Q2 2022 | $614,000 | +117.0% | 16,464 | +73.8% | 0.00% | – |
| Q1 2022 | $283,000 | +38.0% | 9,475 | +58.0% | 0.00% | – |
| Q4 2021 | $205,000 | -7.7% | 5,997 | 0.0% | 0.00% | – |
| Q3 2021 | $222,000 | -5.1% | 5,997 | 0.0% | 0.00% | – |
| Q2 2021 | $234,000 | – | 5,997 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bill & Melinda Gates Foundation | 576,923 | $29,942,304 | 35.70% |
| RTW INVESTMENTS, LP | 6,096,387 | $316,402,485 | 6.68% |
| Paradigm Biocapital Advisors LP | 1,384,686 | $71,865,203 | 4.88% |
| Rock Springs Capital Management LP | 2,943,710 | $152,778,549 | 4.09% |
| Logos Global Management LP | 450,000 | $23,355,000 | 3.12% |
| TANG CAPITAL MANAGEMENT LLC | 405,600 | $21,050,640 | 2.97% |
| GREAT POINT PARTNERS LLC | 290,917 | $15,098,592 | 2.75% |
| Nicholas Investment Partners, LP | 512,855 | $26,617,175 | 1.99% |
| Eschler Asset Management LLP | 30,000 | $1,557,000 | 1.82% |
| COWEN AND COMPANY, LLC | 460,036 | $23,875,868 | 1.67% |